Amgen Inc. Global Capability Center (Hyderabad)

Amgen Inc.'s India Technology and Innovation Centre in Hyderabad represents a landmark investment in the country's biopharmaceutical GCC landscape, reflecting the company's strategic shift toward digital-led drug discovery and manufacturing. Officially inaugurated in February 2025 with an initial $200 million commitment, the centre has rapidly scaled to over 1,500 employees across Hyderabad, Bengaluru, and Mumbai. It operates as a fully owned captive unit under Amgen Technology Private Limited, focusing on artificial intelligence, data science, cloud engineering, and digital innovation to support Amgen's global pipeline of innovative medicines. The Hyderabad site, spanning multiple floors across RMZ Spire and RMZ Nexity towers in HITEC City, serves as the primary hub for this transformation, with capacity planned for up to 3,000 personnel. The centre functions as a technology and innovation powerhouse deploying a sophisticated stack built on AWS, Databricks, Python, TensorFlow, and PyTorch across its AI and data science workflows. Amgen has embedded AI and machine learning capabilities directly into its drug discovery and manufacturing processes, working closely with AWS on generative AI solutions. The India team owns critical systems in clinical development, supply chain analytics, finance automation, and HR technology, with over 600 job postings active across digital innovation, operations, and R&D domains. The site also benefits from the Syngene Amgen Research & Development Centre (SARC) in Bengaluru, a dedicated multi-disciplinary drug discovery centre established in 2016 that has contributed to multiple clinical-stage molecules. Growth momentum at Amgen's India operations remains strong, with plans to expand to over 1 million square feet of office space and a headcount target exceeding 2,000. The company is actively hiring across software engineering, data engineering, cloud engineering, cybersecurity, and AI/ML roles, reflecting deep engineering ownership and a value-creator mandate. Amgen's India GCC is increasingly positioned as a digital transformation hub within the company's global operating model, contributing meaningfully to Amgen's mission of serving patients with serious illnesses while leveraging India's deep talent pool in technology and life sciences.

Parent Enterprise Overview